1. Low-dose solumatrix meloxicam demonstrates low systemic exposure and efficacy in patients with osteoarthitis pain in clinical studies. (April 2015) Authors: Altman, R.; Hochberg, M.; Gibofsky, A.; Kwong, L.; Young, C. Journal: Osteoarthritis and cartilage Issue: Volume 23(2015)Supplement 2 Page Start: A324 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Safety and systemic exposure of triamcinolone acetonide following intra-articular injection of triamcinolone acetonide extended-release or standard triamcinolone in patients with hip osteoarthritis. (April 2019) Authors: Kivitz, A.; Mehra, P.; Hanson, P.; Levy, L.; Kwong, L.; Cinar, A.; Lufkin, J.; Kelley, S. Journal: Osteoarthritis and cartilage Issue: Volume 27(2019)Supplement 1 Page Start: S504 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗